ENTITY
Exelixis Inc

Exelixis Inc (EXEL US)

30
Analysis
Health Care • United States
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
more
Company Presentation • 06 Aug 2026 05:00

Q2 2026

Company Presentation • 06 May 2026 05:00

Q1 2026

Company Presentation • 09 Jan 2024 08:30

J.P. Morgan 42nd Annual Healthcare Conference 2024

Company Presentation • 11 Feb 2026 06:00

Q4 2025

Company Presentation • 06 May 2020 05:00

Q1 2020

x